Sort
40,608 grants matching “prostate cancer”
Commercial development of Src kinase inhibitors for oncology
$326,344Allen Barnett · Kinex Pharmaceuticals, Llc · R44 · FY2010 · CA
Statistical Methods for Prospective Evaluation of Biomarkers
$326,324Yingye Zheng · Fred Hutchinson Cancer Research Center · R01 · FY2014 · GM
Retinoic acid and CRABP-II in regulation of post transcriptional gene silencing
$326,320Donna M Driscoll · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · CA
Retinoic acid and CRABP-II in regulation of post transcriptional gene silencing
$326,320Donna M Driscoll · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA
Retinoic acid and CRABP-II in regulation of post transcriptional gene silencing
$326,320Noa Noy · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · CA
PROJECT 2
$326,300Elizabeth M. Wilson · Univ Of North Carolina Chapel Hill · P01 · FY2009 · CA
Anticarcinogenic Effect of ITCs Against Prostate Cancer
$326,292University Of Pittsburgh At Pittsburgh · R01 · FY2003 · CA
TRIM28 fuels prostate cancer growth through SETDB1-mediated epigenetic silencing of androgen metabolic genes UGT2B15 and UGT2B17
$326,289Ka-Wing Fong · University Of Kentucky · P20 · FY2023 · GM
TRIM28 fuels prostate cancer growth through SETDB1-mediated epigenetic silencing of androgen metabolic genes UGT2B15 and UGT2B17
$326,288Ka-Wing Fong · University Of Kentucky · P20 · FY2022 · GM
TRIM28 fuels prostate cancer growth through SETDB1-mediated epigenetic silencing of androgen metabolic genes UGT2B15 and UGT2B17
$326,281Ka-Wing Fong · University Of Kentucky · P20 · FY2024 · GM
ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER
$326,274Angela M. Brodie · University Of Maryland Baltimore · R01 · FY2006 · CA
Project 1: Molecular Mechanisms Initiating Prostate Cancer Metastasis
$326,259Leland W. Chung · Cedars-Sinai Medical Center · P01 · FY2015 · CA
SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SELECT) FOR PROSTATE CANCER
$326,257University Of Colorado Denver · M01 · FY2005 · RR
THE ROLE OF S100A4 IN PROSTATE CANCER BONE METASTASIS
$326,250University Of Alabama At Birmingham · · FY2008 · Department of the Army
Chemical Inhibitors of CREB-mediated Gene Transcription
$326,240Xiangshu Xiao · Oregon Health & Science University · R01 · FY2010 · GM
A novel T-cell subset able to kill relapsed cancers
$326,231Qing Yi · Methodist Hospital Research Institute · R01 · FY2018 · CA
THE GENETIC EPIDEMIOLOGY OF COMPLEX TRAITS
$326,230University Of Washington · R01 · FY2000 · GM
RADIOLABELED ANTIBODIES TARGETING LAT1 FOR IMAGING AND THERAPY OF PROSTATE CANCER
$326,174Suzanne Elizabeth Lapi · University Of Alabama At Birmingham · R01 · FY2019 · CA
Mitochondria in Prostate Cancer Diversity
$326,174Keshav K. Singh · University Of Alabama At Birmingham · R01 · FY2019 · CA
Novel Inhibitors of Prostate Cancer Progression
$326,168Ajit K Verma · University Of Wisconsin-Madison · R01 · FY2014 · CA
Identification of key players mediating internalization of Trichomonas vaginalis extracellular vesicles by host cells and parasite adherence and survival in vivo
$326,162Patricia Jean Johnson · University Of California Los Angeles · R01 · FY2023 · AI
Core A: Leadership and Administrative
$326,081Peter S Nelson · Fred Hutchinson Cancer Center · P50 · FY2023 · CA
Prostate cancer prevention by selenium supplementation
$326,066Rayudu Gopalakrishna · University Of Southern California · R01 · FY2011 · CA
Prostate cancer prevention by selenium supplementation
$326,066Rayudu Gopalakrishna · University Of Southern California · R01 · FY2012 · CA
Hyaluronic Acid Based Nanoparticles for Targeted Image-Guided Tumor Surgery
$326,008Aaron M. Mohs · University Of Nebraska Medical Center · R01 · FY2016 · EB